Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the short-term effects of tofogliflozin on insulin secretory capacity in type 2 diabetes. It found significant improvements in several metabolic markers.
Bariatric surgery significantly reduced cardiovascular disease risk factors in Emirati individuals with type 2 diabetes.
This study investigated the anti-aging effects of Henagliflozin in patients with Type 2 diabetes, finding an increase in telomere length and other biomarkers.
This study investigated the effects of intermittent fasting strategies on weight loss and insulin resistance in night shift workers, finding no significant differences in body weight or insulin resistance compared to continuous energy restriction.
This study evaluated the efficacy of once-daily oral semaglutide 25 mg in adults with obesity and type 2 diabetes, finding significant weight reduction compared to placebo.
This study compared the effectiveness of Roux-en-Y gastric bypass (RYGB) and a very low-calorie diet (VLCD) in individuals with obesity, finding no significant differences in weight loss outcomes.
AndroidAPS, an open-source automated delivery system, in adults with type 1 diabetes.
This study characterized continuous glucose monitoring data in patients with Type 2 diabetes in China, revealing associations between glycemic metrics and various factors.
This study evaluated the effects of canagliflozin on cardiovascular and kidney outcomes in individuals with type 2 diabetes, finding a reduction in major adverse cardiovascular events.
This study evaluated the effects of canagliflozin combined with metformin on cardiovascular risk in patients with type 2 diabetes mellitus, finding a significant reduction in major adverse cardiovascular events.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
